Navigation Links
DARA in Medical News

Sports Icons Troy Aikman, Clyde Drexler, Mike Piazza, Ivan Lendl and Dara Torres are Among the Elite Named 2009 'Great Sports Legends'

NEW YORK, Aug. 3 /PRNewswire/ -- Sports icons and philanthropy champions will be spotlighted when they gather at the 24 (th) Annual Great Sports Legends Dinner on Tuesday, October 6 , at New York's Waldorf=Astoria Hotel in the famed Grand Ballroom. Bob Costas will host the pro...

Swimmer Dara Torres Sports a White Upper Lip to Praise Milk as Her Post-Exercise Fitness Drink

Medal-Winning Mom 'Laps' Up Lowfat Milk to Help Keep Her Muscles and Bones in Top Shape WASHINGTON, April 8 /PRNewswire/ -- With summer on the horizon, millions of women have their sights on shedding bulky sweaters for swimsuits. Yet, award-winning swimmer and mom Dara Torres, 41, knows ther...

AAHSA Expert To Speak To Help Committee Briefing on Health Care Reform and Long-Term Services and Support

... Harkin to Host Event With Olympic Swimmer dara Torres WASHINGTON, June 7 /PRNewswire...or individuals with disabilities. Also speaking is dara Torres, a 10-time Olympic medalist in swimming, wh...rida. WHO: Senator Tom Harkin (D-IA) dara Torres, 10-time Olympic medalist, and long-term s...

Milkshakes are medicine for anorexic teens in family-based outpatient therapy

...egain the weight on his or her own. Nutritional rehabilitation gives the brain the nutrition it needs to re-establish healthy eating habits," says Dr. dara Bellace, a clinical psychologist at NewYork-Presbyterian Hospital/Westchester Division and an instructor of psychology in psychiatry at Weill Cornell ...

Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease

...isease conventional treatment is not feasible, researchers say. Among the technical hurdles to improving blood flow in such patients, according to dara L. Kraitchman, V.M.D., Ph.D., associate professor of radiology at Johns Hopkins, is a means of telling doctors whether injected stem cells are staying...

'Seeing' Stem Cells Helps in Fight Against Peripheral Arterial Disease

...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine . Transplanting stem cells derived from bone marrow (not emb...

U-M Health Minute: Today's Top Health Issues and Medical Research

...ly represent the views of the Department of Veterans Affairs. Authors: In addition to Valenstein, authors of the paper were Hyungjin Myra Kim, dara Ganoczy, John F. McCarthy, Kara Zivin, Karen L. Austin, Katherine Hoggatt, Daniel Eisenberg, John D. Piette and Frederic C. Blow, all with affiliation...

Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)

...14th, New Yorkers will receive their purchases in the limited edition bags. "We are very thankful to have the generous support of Duane Reade," said dara P. Richardson-Heron, MD, CEO of Komen Greater New York City. "In 2008, more than 170,000 people will be diagnosed with breast cancer and 40,000 will d...

Rochester Medical Marketing VP Retires

...irstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM ) today announced dara Lynn Horner's retirement from the position of Vice President -- Marketing. ... a fine contributor, but Rochester Medical's loss will be the world's gain. dara Lynn will be very supportive of all our efforts through the transition and ...

DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation

... RALEIGH, N.C., April 16 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today that Surgi-Vision, Inc., a privately held company of which dara Biosciences owns approximately 9.8% of the outstan...
DARA in Medical Technology

Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540

PRINCETON, N.J., April 15 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP ), an innovator in the discovery and development of novel small molecule therapeutics, announced today that results from the company's Phase 2a clinical trial evaluating PS433540, its first-in-class Dual Acting Rec...

Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial

PS433540 Shown to Be Well Tolerated and Potentially Suited for Once Daily Administration PRINCETON, N.J., April 10, 2007 /PRNewswire-FirstCall/ -- Pharmacopeia , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Ph...

Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients

...ents include, but are not limited to, statements about the results of Pharmacopeia's Phase 2a clinical study of PS433540, a product candidate from its dara program, Pharmacopeia's plans to develop PS433540, Pharmacopeia's other Phase 2 and Phase 1 clinical studies with respect to PS433540, including timin...

Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)

... Phase 2b Trial to Examine Safety and Efficacy of dara versus Active Control PRINCETON, N.J., March 3 /...433540 with irbesartan. "We are pleased with the dara program's rapid progress. This is our second Phase... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...

Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)

...ensive patients, we are pleased to have the opportunity to demonstrate that dara can effectively lower blood pressure in this patient population." Results...ans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...

Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development

... Company Also Provides Update on dara Program's Ongoing Phase 2a Hypertension Study P...ram, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...

Pharmacopeia to Present at BIO CEO & Investor Conference 2008

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)

... compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Third Quarter 2007 Financial Results

...macopeia Advances and Expands Internal Pipeline as dara Program Enters Phase 2 Clinical Development ...540, an unpartnered product candidate from its dara program, that is both an angiotensin receptor bloc... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...

Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 1 and Phase 2 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...
DARA in Biological News

'Seeing' stem cells helps in fight against peripheral arterial disease

...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine. Transplanting stem cells derived from bone marrow (not embry...

Magnetic probe successfully tracks implanted cells in cancer patients

...he Netherlands. "The cells can't get from the fat into the lymph nodes by themselves, so injecting them properly is very important." Bulte says he, dara Kraitchman, Ph.D., D.V.M., and colleagues at Hopkins are already testing magnetically labeled stem cells with MRI-compatible injection systems to allo...
DARA in Biological Technology

RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer

...h was also previously with the R&D organization of the Janssen Research Foundation in Belgium. Dr. Cauwenbergh currently serves as a Board member of dara Biosciences, Upstream Biosciences as well as Ablynx NV, and is a member of the Board of Trustees, and Vice Chairman of Bio New Jersey. Since 2004, Dr....

Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline

... compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

Pharmacopeia Announces Management Team Changes

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...

DARA BioSciences, Inc. Announces Appointment of New Director to Board

... RALEIGH, N.C., Feb. 27 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today the appointment of Haywood D. Co... of seven other publicly-traded companies. About dara BioSciences, Inc. ...

DARA BioSciences to Present at the ROTH Growth Stock Conference

... RALEIGH, N.C., Feb. 4 /PRNewswire/ -- dara BioSciences, Inc. today announced that the Company...on will be available at the same location. About dara BioSciences, Inc. dara BioSciences(TM), Inc. ("DARA") is a Raleigh, North...

Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference

...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...
Other Tags
(Date:4/21/2015)... 21, 2015 Henry Mayo Newhall Hospital, ... Care Exchange to automatically send continuation of care ... to further improve communication with clinics and other ambulatory ... Alert solution. , “Provider Alert will enable ... patient information they need to provide continuing care in ...
(Date:4/21/2015)... Among parents of children with autism spectrum disorder, ... or poor, according to a study in the journal ... to the dentist can present many challenges for a ... smells, loud noises, and sharp tools; the unfamiliarity of ... whole process—not knowing what will happen and when it ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Top medical ... in India for their ongoing commitment to providing superior ... strives to provide patients with the best possible experience ... skin, hair and body. , Executives at Ojas Aesthetic ... the philosophy of — nothing about you, without you ...
(Date:4/21/2015)... TX (PRWEB) April 21, 2015 The ... announced today it is opening its first freestanding emergency ... in Chandler, Arizona and will be licensed under Dignity ... the Dignity Health and Adeptus Health joint venture. , ... Regional and Mercy Gilbert Medical Centers said the new ...
(Date:4/21/2015)... Calif. (PRWEB) April 21, 2015 Information is ... , Kevin Ryan, MD, FACP, empowers patients and their families ... Tumor is the Rumor and Cancer is the Answer" and ... authoritative and informative language to guide patients from diagnosis through ... make patients active participants in their treatment, at home and ...
Breaking Medicine News(10 mins):Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
Other Contents